Perioperative mortality for management of hepatic neoplasm: A simple risk score

Annals of Surgery

Volumn 250, Issue 6, 2009, Pages 929-934

  Simons, Jessica P ^a   Hill, Joshua S ^a   Ng, Sing Chau ^a   Shah, Shimul A ^a   Zhou, Zheng ^a   Whalen, Giles F ^a   Tseng, Jennifer F ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; ELECTROSURGERY; FEMALE; HUMAN; LIVER CANCER; LIVER LOBECTOMY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCORING SYSTEM; SURGICAL MORTALITY;

AGED; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HOSPITAL MORTALITY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 73449085146     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181bc9c2f     Document Type: Article

References (51)

1. El-Serag HB, Davila JA, Petersen NJ, et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med. 2003;139:817-823.
2. Hemming AW, Reed AI, Howard RJ, et al. Preoperative portal vein embo-lization for extended hepatectomy. Ann Surg. 2003;237:686-691.
3. Ng KK, Vauthey JN, Pawlik TM, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol. 2005;12:364-373.
4. Hemming AW, Reed AI, Fujita S, et al. Role for extending hepatic resection using an aggressive approach to liver surgery. J Am Coll Surg. 2008;206: 870-875.
5. D'Angelica M, Brennan MF, Fortner JG, et al. Ninety-six five-year survivors after liver resection for metastatic colorectal cancer. J Am Coll Surg. 1997; 185:554-559.
6. Harms J, Obst T, Thorban S, et al. The role of surgery in the treatment of liver metastases for colorectal cancer patients. Hepatogastroenterology. 1999;46: 2321-2328.
7. Steele G Jr, Bleday R, Mayer RJ, et al. A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol. 1991;9:1105-1112.
8. Buell JF, Rosen S, Yoshida A, et al. Hepatic resection: effective treatment for primary and secondary tumors. Surgery. 2000;128:686-693.
9. Berney T, Mentha G, Roth AD, et al. Results of surgical resection of liver metastases from non-colorectal primaries. Br J Surg. 1998;85:1423-1427.
10. Harrison LE, Brennan MF, Newman E, et al. Hepatic resection for noncolo-rectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery. 1997;121:625-632.
11. Alseidi A, Helton WS, Espat NJ. Does the literature support an indication for hepatic metastasectomy other than for colorectal primary? J Gastrointest Surg. 2006;10:99-104.
12. Oshowo A, Gillams A, Harrison E, et al. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg. 2003;90:1240-1243. (Pubitemid 37330428)
13. Pawlik TM, Izzo F, Cohen DS, et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003;10:1059-1069.
14. Elias D, Baton O, Sideris L, et al. Local recurrences after intraoperative radiofrequency ablation of liver metastases: a comparative study with anatomic and wedge resections. Ann Surg Oncol. 2004;11:500-505.
15. Aloia TA, Vauthey JN, Loyer EM, et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006;141:460-466.
16. Sutherland LM, Williams JA, Padbury RT, et al. Radiofrequency ablation of liver tumors: a systematic review. Arch Surg. 2006;141:181-190.
17. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer. 1985;56:918-928.
18. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis. 1999;19:329-338.
19. Kudo M, Chung H, Osaki Y. Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroen-terol. 2003;38:207-215.
20. Ikai I, Yamamoto Y, Yamamoto N, et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am. 2003;12:65-75, ix
21. Liver (Including intrahepatic bile ducts). In: Green FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Handbook. New York: Springer; 2002:131-144.
22. Pawlik TM, Tseng JF, Vauthey JN. Controversies in the staging of hepato-cellular carcinoma. Cancer Rev. 2003;1:179-189.
23. Seo YS, Kim YJ, Um SH, et al. Evaluation of the prognostic powers of various tumor status grading scales in patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2008;23(8 pt 1):1267-1275.
24. Gayowski TJ, Iwatsuki S, Madariaga JR, et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery. 1994;116:703-710.
25. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer. 1996;77:1254-1262.
26. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg. 1999;230:309-318.
27. Mann CD, Metcalfe MS, Leopardi LN, et al. The clinical risk score: emerging as a reliable preoperative prognostic index in hepatectomy for colorectal metastases. Arch Surg. 2004;139:1168-1172.
28. Belghiti J, Hiramatsu K, Benoist S, et al. Seven hundred forty-seven hepa-tectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000;191:38-46.
29. Dimick JB, Cowan JA Jr, Knol JA, et al. Hepatic resection in the United States: indications, outcomes, and hospital procedural volumes from a nationally representative database. Arch Surg. 2003;138:185-191.
30. Virani S, Michaelson JS, Hutter MM, et al. Morbidity and mortality after liver resection: results of the patient safety in surgery study. J Am Coll Surg. 2007;204:1284-1292.
31. International Classification of Diseases, 9th Revision, Clinical Modification. Salt Lake City, UT: Medicode Publications; 2001.
32. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
33. Romano PS, Roost LL, Jollis JG. Presentation adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-1079.
34. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1803 consecutive cases over the past decade. Ann Surg. 2002;236:397-406.
35. Helling TS. Ruminations of an ordinary hepatic surgeon: a journey through the pitfalls of major liver resections. J Gastrointest Surg. 2002;6:625-629.
36. Ston ME Jr, Rehman SU, Conaway G, et al. Hepatic resection at a community hospital. J Gastrointest Surg. 2000;4:349-353.
37. Song T-J, Wai Kit Ip E, Fong Y. Hepatocellular carcinoma: current surgical management. Gastroenterology. 2004;127(5 suppl 1):S248-S260.
38. Yanaga K. Current status of hepatic resection for hepatocellular carcinoma. J Gastroenterol. 2004;39:919-926.
39. Kuvshinoff B, Fong Y. Surgical therapy of liver metastases. Semin Oncol. 2007;34:177-185.
40. Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94:982-999.
41. Child CG, Turcotte JG. Surgery and portal hypertension. Major Probl Clin Surg. 1964;1:1-85.
42. Schneider PD. Preoperative assessment of liver function. Surg Clin North Am. 2004;84:355-373.
43. Vallejo R, Hord ED, Barna SA, et al. Perioperative immunosuppression in cancer patients. J Environ Pathol Toxicol Oncol. 2003;22:139-146.
44. McGhana JP, Dodd GD III. Radiofrequency ablation of the liver: current status. Am J Roentgenol. 2001;176:3-16.
45. Apgar V. A proposal for a new method of evaluation of the newborn infant. Curr Res Anesth Analg. 1953;32:260-267.
46. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835-842.
47. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
48. Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9-13.
49. Eppsteiner RW, Csikesz NG, Simons JP, et al. High volume and outcome after liver resection: surgeon or center? J Gastrointest Surg. 2008;12:1534-1539.
50. Csikesz NG, Simons JP, Tseng JF, et al. Surgical specialization and operative mortality in hepato-pancreatico-biliary (HPB) surgery. J Gastrointest Surg. 2008;12:1534-1539.
51. Asiyanbola B, Chang D, Gleisner AL, et al. Operative mortality after hepatic resection: are literature-based rates broadly applicable? J Gastrointest Surg. 2008;12:842-851.